The Latest

  • Addiction brain
    Image attribution tooltip
    Rafik via Getty Images

    AI company zeros in on compounds to treat addiction by rewiring the brain

    GATC Health is driving a novel approach it believes could work for several major neurological conditions.

  • Image attribution tooltip
    Sarah Silbiger via Getty Images

    An FDA proposal could make OTC switches easier. Here’s what the industry has to say

    How the FDA’s proposal to create a new OTC approval pathway could impact the pharma industry.

  • lightbulb breaking
    Image attribution tooltip
    Stock via Getty Images
    Opinion

    Healthcare tech’s biggest busts

    The metaverse, blockchain, DCTs and more — here are some of the most recent fails in healthcare tech.

  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020, in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images

    5 final FDA action dates to watch this year

    A potential flurry of regulatory activity could be on the horizon yet this year — and several key drug approvals are at stake.

  • Overhead view of a person holding two white pills in their left hand and a glass of water in their right hand.
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    Non-toxic and addiction free: The promise of a new pain med

    Why South Rampart Pharma’s novel new molecule could be a key to solving the global pain epidemic.

  • pills
    Image attribution tooltip
    Stock via Getty Images

    10 of our most popular articles in 2022

    Methadone, rock ‘n’ roll, clinical trial overhauls — here’s a look at our most-read stories of the year.

  • Alison O'Neill B&W head shot
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Surface Oncology’s Dr. Alison O’Neill

    With more than two decades of experience in oncology R&D, Dr. Alison O’Neill is helping Surface unlock the potential of next-gen immunotherapies by targeting the tumor microenvironment.

  • Barry Sherman
    Image attribution tooltip

    Al Dunlop/ZUMA Press/Newscom

    5 enduring mysteries of the Barry and Honey Sherman murders

    After nearly five years, the homicide case involving pharma billionaires continues to perplex investigators.

  • A team of four people wearing white lab coats stand looking at a computer in a medical science laboratory.
    Image attribution tooltip
    Stock via Getty Images

    One biotech’s approach to science-driven innovation

    Why some in the industry say fostering creativity in drug development is all about work structures.

  • Skin
    Image attribution tooltip
    Ivan Balvan via Getty Images
    Q&A // Biotech Spotlight

    Evommune’s unique method of drug discovery is more than skin deep

    The biotech is using human skin squares from plastic surgery to find the best immunological molecules for solving conditions like dermatitis.

  • Psychedelic
    Image attribution tooltip
    Danylana via Getty Images

    Avoiding a ‘bad trip’ in psychedelic clinical trials

    Psychedelic drug trials pose a number of challenges, but researchers can take these steps to boost patient safety.

  • A view of a sign that reads, "Kendall square: central square, Harvard square, cinema" is framed by a pill outline.
    Image attribution tooltip

    Photo illustration: Shaun Lucas and Karissa Waddick/Industry Dive; Getty Images 

    The next era of Greater Boston’s biotech boom

    How Boston became the biotech capital of the U.S., and is now preparing for the next era of life sciences growth.  

  • A building showing a logo of Teva Pharmaceutical
    Image attribution tooltip
    Courtesy of Teva Pharmaceutical

    Executive changes at Teva, Eversana could spell commercial growth in the new year

    With their latest personnel moves, these life sciences companies are preparing for major business shifts.

  • Nicole Lambert WoW picture
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Myriad Genetics’ Nicole Lambert

    Empowered by her own cancer journey, Nicole Lambert is using her platform as chief operating officer of the genetic testing powerhouse to change the trajectory of care for millions of women.

  • Professional headshot of Evelina Vågesjö
    Image attribution tooltip

    Permission granted by Evelina Vågesjö 

    Profile

    How bacteria-enabled technology for wounds could also help cancer patients

    Evelina Vågesjö, co-founder and CEO of the immunotherapy company Ilya Pharma, is working on a new modality to speed wound healing.

  • lab tubes
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    In cancers with very low survival rates, Sellas aims higher

    The company hopes its drugs can “take over where other available treatments fail” in multiple types of cancer.

  • IPO
    Image attribution tooltip
    AndreyPopov via Getty Images

    Why the biopharma ‘IPO playbook’ changed in 2022

    Biopharma IPOs have puttered in 2022, particularly compared to the record-breaking previous year, but they might be set to rebound.

  • office red
    Image attribution tooltip
    Stock via Getty Images
    Opinion

    Hybrid work is here to stay — here’s how leaders should adjust

    Executives across the life sciences share their tips for navigating the new norm of remote work.

  • Close up of a woman's hand holding a smart phone with a heart icon.
    Image attribution tooltip
    iStock via Getty Images

    4 pioneering social media campaigns in pharma this year

    The key to a great social media campaign is often simplicity, and these pharma companies hit the nail on the head with unique strategies that aim to educate. 

  • Artificial intelligence in healthcare
    Image attribution tooltip
    ArtemisDiana via Getty Images

    Is AI just hype or a real revolution in pharma? It’s complicated

    Artificial intelligence can be a useful tool and will likely augment many processes in biopharma — but it's still early days, and hype is rampant.

  • Francisco Barriga and Kaloyan Tsanov of the Sloan Kettering Institute
    Image attribution tooltip
    Permission granted by Memorial Sloan Kettering Cancer Center

    To explore cancer’s genetic mysteries, researchers turn to ‘MACHETE’

    A new CRISPR-based tool could help scientists understand and better treat cancer by revealing the complex genetic mutations that occur.

  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Janssen’s Najat Khan

    Janssen’s Najat Khan, Ph.D., chief data science officer and global head of strategy and operations, shares how the company is using next-gen tech to ‘reimagine’ medicine.

  • HLTH conference 2022
    Image attribution tooltip
    Meagan Parrish/PharmaVoice

    #HLTH: ‘Unicorns are real’ — and here’s how they can navigate a challenging biotech market

    Venture capitalists tackle ways companies can stay afloat while the market’s turbulent waters rise.

  • Professional headshot of Sana Alajmovic.
    Image attribution tooltip

    Permission granted by Sana Alajmovic

    Profile

    A ‘bold vision’ to prevent diabetes

    Despite hearing that there’s “no money in prevention,” the CEO of Sigrid Therapeutics is forging ahead with the company’s goal of stopping Type 2 diabetes before it starts. 

  • COVID vaccine development
    Image attribution tooltip
    iStock via Getty Images

    4 ways to bring COVID’s ‘warp speed’ to the next era of drug development

    An IQVIA Institute for Human Data Science report outlines how companies can improve communication, recruitment, data and investing strategies to accelerate clinical trial timelines.